Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gene hunt aims to stop antidepressant agitation in kids

NCT ID NCT03953014

First seen May 15, 2026 · Last updated May 22, 2026 · Updated 2 times

Summary

This study looks at whether a child's genes can predict if they will have a rare but serious side effect from common antidepressants (SSRIs) called behavioral disinhibition, which can cause agitation or impulsivity. Researchers will collect saliva samples from 120 children and young adults (ages 6-24) with depression, anxiety, or OCD who have taken or are taking SSRIs. The goal is to find genetic markers that could help doctors choose safer treatments in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Child and Adolescent Addiction, Mental Health & Psychiatry

    RECRUITING

    Calgary, Alberta, Canada

    Contact

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.